NDT Advance Access published online on January 30, 2009
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn654
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism
1 S. Anna School of Advanced Studies, Nephrology and Dialysis Unit, Department of Internal Medicine, University of Pisa, Italy 2 Nephrology and Dialysis Unit, Department of Internal Medicine, University of Pisa, Italy
Correspondence and offprint requests to: Mario Meola, Nephrology and Dialysis Unit, Department of Internal Medicine, University of Pise, Hospital of Cisanello, Via Paradisa, 2 - 56127 Pise, Italy. Tel: +39-050-997260; Fax: +39-050-997285; E-mail: mmeola{at}int.med.unipi.it
 |
Abstract |
|---|
Background. The effect of cinacalcet on the structural pattern of hyperplastic parathyroid glands was evaluated, using high-resolution colour Doppler (CD) sonography, in haemodialysis patients with severe, inadequately controlled, secondary hyperparathyroidism (sHPT).
Methods. Nine patients (6 males, 3 females; mean age ± SD, 55.5 ± 12.6 years) received cinacalcet, with adaptation of existing concomitant therapies. Biochemical parameters and the morphology and vascular pattern of hyperplastic parathyroid glands were measured at baseline and every 6 months thereafter, for a follow-up period of 24–30 months.
Results. At baseline, 28 hyperplastic glands were identified. Cinacalcet led to a reduction in glandular volume during the course of the study: 68% in glands with a baseline volume <500 mm3 and 54% in glands with a baseline volume 
500 mm3. The mean volume ± SD of glands <500 mm3 changed significantly from the baseline (233 ± 115 mm3) to the end of follow-up (102 ± 132 mm3, P = 0.007). Levels of mean serum phosphorus, calcium and calcium–phosphorus product decreased, but not significantly, whereas there were significant decreases in mean parathyroid hormone ± SD levels (1196 ± 381 pg/ml versus 256 ± 160 pg/ml; P < 0.0001) and alkaline phosphatase ± SD levels (428 ± 294 versus 223 ± 88 IU/l; P = 0.04), accompanied by an improvement in a subjective clinical score.
Conclusions. Cinacalcet, in combination with conventional treatments, led to an improvement in biochemical and clinical parameters of sHPT and reduced glandular volume in patients with severe sHPT. Volume reduction was more evident in smaller glands. Longer term, larger, randomized clinical trials are needed to confirm these preliminary findings and to further define a more systematic approach in the treatment of sHPT.
Keywords: chronic kidney disease; cinacalcet; high-resolution sonography; parathyroid hyperplasia; secondary hyperparathyroidism
Received for publication: 10. 4.08
Accepted in revised form: 31.10.08
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Komaba, J. Shin, and M. Fukagawa Restoration of reversed whole PTH/intact PTH ratio and reduction in parathyroid gland vascularity during cinacalcet therapy for severe hyperparathyroidism in a uraemic patient Nephrol. Dial. Transplant., November 5, 2009; (2009) gfp578v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yokoyama Cinacalcet Hydrochloride in Chronic Kidney Disease-Mineral Bone Disorder Clin. J. Am. Soc. Nephrol., September 1, 2009; 4(9): 1405 - 1408. [Full Text] [PDF]
|
|
|
|
|
|
H. Komaba and M. Fukagawa Regression of parathyroid hyperplasia by calcimimetics--fact or illusion? Nephrol. Dial. Transplant., March 1, 2009; 24(3): 707 - 709. [Full Text] [PDF]
|
|